Targher, Giovanni

Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity

Lonardo, A., Mantovani, A., Lugari, S., & Targher, G. (2020) · Annals of Hepatology

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 150

Association between diabetes and 1-year adverse clinical outcomes in a multinational cohort of ambulatory patients with chronic heart failure: results from the ESC-HFA heart failure long-term registry

Dauriz, M., Targher, G., Laroche, C., Temporelli, P. L., Ferrari, R., Anker, S., Coats, A., Filippatos, G., Crespo-Leiro, M., Mebazaa, A., et al. (2017) · Diabetes Care

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 139

Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials

Mantovani, A., Byrne, C. D., Scorletti, E., Mantzoros, C. S., & Targher, G. (2020) · Diabetes & Metabolism

Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management

Cited by 138

Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals

Mantovani, A., Petracca, G., Csermely, A., Beatrice, G., Bonapace, S., Rossi, A., Tilg, H., Byrne, C. D., & Targher, G. (2023) · Gut

Liver Disease Diagnosis and TreatmentHeart Failure Treatment and Management

Cited by 128

Prognostic impact of diabetes on long-term survival outcomes in patients with heart failure: a meta-analysis

Dauriz, M., Mantovani, A., Bonapace, S., Verlato, G., Zoppini, G., Bonora, E., & Targher, G. (2017) · Diabetes Care

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 123

Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver disease

Targher, G., Mantovani, A., & Byrne, C. D. (2023) · The Lancet Gastroenterology & Hepatology

Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management

Cited by 121

Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes

Mantovani, A., Mingolla, L., Rigolon, R., Pichiri, I., Cavalieri, V., Zoppini, G., Lippi, G., Bonora, E., & Targher, G. (2016) · International Journal of Cardiology

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 82

NASH drug treatment development: challenges and lessons

Tilg, H., Byrne, C. D., & Targher, G. (2023) · The Lancet Gastroenterology & Hepatology

Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects

Cited by 81

Prevalence of cardiovascular autonomic neuropathy in a cohort of patients with newly diagnosed type 2 diabetes: the Verona Newly Diagnosed type 2 Diabetes Study (VNDS)

Zoppini, G., Cacciatori, V., Raimondo, D., Gemma, M., Trombetta, M., Dauriz, M., Brangani, C., Pichiri, I., Negri, C., Stoico, V., et al. (2015) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 74

Hyperthyroidism and venous thrombosis: a casual or causal association? A systematic literature review

Franchini, M., Lippi, G., & Targher, G. (2011) · Clinical and Applied Thrombosis/Hemostasis

Thyroid Disorders and TreatmentsVenous Thromboembolism Diagnosis and Management

Cited by 71

Prognostic impact of diabetes and prediabetes on survival outcomes in patients with chronic heart failure: a post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial

Dauriz, M., Targher, G., Temporelli, P. L., Lucci, D., Gonzini, L., Nicolosi, G. L., Marchioli, R., Tognoni, G., Latini, R., Cosmi, F., et al. (2017) · Journal of the American Heart Association

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 70

Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes

Mantovani, A., Sani, E., Fassio, A., Colecchia, A., Viapiana, O., Gatti, D., Idolazzi, L., Rossini, M., Salvagno, G., Lippi, G., et al. (2019) · Diabetes & Metabolism

Bone health and osteoporosis researchLiver Disease Diagnosis and Treatment

Cited by 68

The effect of iron depletion on chronic hepatitis C virus infection

Franchini, M., Targher, G., Capra, F., Montagnana, M., & Lippi, G. (2008) · Hepatology International

Hepatitis C virus researchIron Metabolism and Disorders

Cited by 58

Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance

Cacciatori, V., Zoppini, G., Bellavere, F., Rigolon, R., Thomaseth, K., Pichiri, I., Trombetta, M., Dauriz, M., De Santi, F., Targher, G., et al. (2018) · Journal of the Endocrine Society

Heart Rate Variability and Autonomic ControlDiabetes Treatment and Management

Cited by 18

Serum dithiothreitol-oxidizing capacity (DOC) is a promising biomarker for excluding significant liver fibrosis: a proof-of-concept study

Yang, L., Zhang, Y., Hong, X., Zhang, K., Liu, B., Zhang, P., Tang, Q., Yu, J., Jin, X.-Z., Jin, X.-Z., et al. (2024) · BMC Medicine

Liver Disease Diagnosis and TreatmentLiver Disease and Transplantation

Cited by 7

FRI-267 Regional fibrosis progression analysed by digital pathology with artificial intelligence is associated with renal dysfunction

Sun, D.-Q., Shen, J.-Q., Tong, X.-F., Li, Y., Targher, G., Ren, Y., Yuan, H., Byrne, C. D., You, H., & Zheng, M.-H. (2024) · Journal of Hepatology

Liver Disease Diagnosis and TreatmentChronic Kidney Disease and Diabetes

Cited by 1